Unusual complication of vemurafenib treatment of metastatic melanoma: exacerbation of acantholytic dyskeratosis complicated by Kaposi varicelliform eruption

Arch Dermatol. 2012 Aug;148(8):966-8. doi: 10.1001/archdermatol.2012.758.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acantholysis / chemically induced*
  • Acantholysis / complications
  • Aged
  • Antineoplastic Agents / adverse effects
  • Drug Eruptions / etiology
  • Female
  • Humans
  • Ichthyosis / chemically induced*
  • Ichthyosis / complications
  • Indoles / adverse effects*
  • Kaposi Varicelliform Eruption / chemically induced*
  • Kaposi Varicelliform Eruption / complications
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / secondary
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Sulfonamides / adverse effects*
  • Vemurafenib

Substances

  • Antineoplastic Agents
  • Indoles
  • Sulfonamides
  • Vemurafenib

Supplementary concepts

  • Grover's disease